Catalyst Watch: Microsoft earnings, Boeing buzz, FOMC meeting, and fintech IPOs
Source: SeekingAlpha
2026-01-23 15:00:01 ET
More on the markets
- Markets On Thin Ice: Greenland Framework, Japan's Yield Shock, And A Fragile Tape
- Trump 2.2: Can The Market Keep Rallying In His Second Year Of Presidency?
- Will U.S. Q4 Growth Exceed Q3's Strong Pace?
- Trump says U.S. negotiating 'total access' to Greenland - report
- Rick Rieder gains noticeable momentum in Fed Chair race, according to Polymarket
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Microsoft earnings, Boeing buzz, FOMC meeting, and fintech IPOs
ImmunityBio Inc.
NASDAQ: IBRX
IBRX Trading
7.37% G/L:
$8.5414 Last:
17,220,926 Volume:
$8.21 Open:
IBRX Latest News
March 13, 2026 07:30:00 am
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
March 09, 2026 07:30:00 am
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
March 05, 2026 10:20:00 am
Forget ImmunityBio: This Big?Cap Pharma Is the Safer Play on Next?Gen Cancer Therapies
February 27, 2026 07:30:00 am
ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026
IBRX Stock Data
$6,497,322,803
300,611,373
0.32%
122
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
